Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: Updated systematic review and meta-analysis of randomized controlled trials.
Florian MoikFlorian PoschChristoph ZielinskiIngrid PabingerCihan AyPublished in: Research and practice in thrombosis and haemostasis (2020)
In patients with cancer-associated VTE, DOACs are more effective in preventing recurrent VTE compared to LMWH. However, risk of bleeding is increased with DOACs, especially in patients with GI cancer.